Philip A. Philip, MD

Philip A. Philip, MD, is the director of Gastrointestinal Oncology, co-director of the Pancreatic Cancer Center, and medical director of Research and Clinical Care Integration at the Henry Ford Cancer Institute

Articles by Philip A. Philip, MD

Image by Ashling Wahner & MJH Life Sciences Using AI

Dr Philip on the Mechanism of Action of TTFields in Locally Advanced Pancreatic Cancer

ByPhilip A. Philip, MD

September 28th 2026

Philip A. Philip, MD, discusses how tumor treating fields work and their role in locally advanced pancreatic cancer following the Optune Pax FDA approval.

Exploring the FDA Approval of Optune Pax and What It Means for Locally Advanced Pancreatic Cancer

ByPhilip A. Philip, MD

September 28th 2026

Philip A. Philip, MD, discusses TTFields in pancreatic cancer and what phase 3 data has shown in locally advanced disease.

Philip A. Philip, MD

Articles by Philip A. Philip, MD

Dr Philip on the Mechanism of Action of TTFields in Locally Advanced Pancreatic Cancer

Exploring the FDA Approval of Optune Pax and What It Means for Locally Advanced Pancreatic Cancer

Latest Updated Articles

Trending on OncLive

Cardiovascular and Bleeding Risk With BTK Inhibitors in CLL

FDA Approves Durvalumab Plus Enfortumab Vedotin for Cisplatin-Ineligible MIBC

Dr Calais on Individualizing PSMA-Targeted Therapy Sequencing in Prostate Cancer

CHMP Recommends Approval of Belzutifan Plus Lenvatinib for Advanced ccRCC After PD-(L)1 Inhibition

NDA Submission Completed for Zipalertinib Plus Chemotherapy in Frontline EGFR Exon 20 Insertion–Positive NSCLC